Among post-stroke patients taking, whether depressed or not, fluoxetine or nortriptyline for 12 weeks in the first 6 months after stroke, long-term mortality is significantly lower than among patients not treated with antidepressants or treated for less time.

a 9-year randomised, double-blind study of 104 post-stroke patients using nortriptyline, fluoxetine or placebo